Hubungan Derajat Fibrosis Hati Dengan Skor Apri Dibandingkan Dengan Fibroscan Pada Pasien Hepatitis B Dan C Kronik
BAB VII
DAFTAR PUSTAKA
Akbar HN (2007). Hepatitis B dan Hepatitis C. Dalam : Sulaiman A. Akbar HN.
Lesmana LA. Noer MS. Ed: Buku Ajar Penyakit Hati. Edisi 1. Jakarta:
FK.UI; 201-8
Afdhal NH, Nunes D (2004). Evaluation of liver fibrosis: a concise review. Am J
Gastroenterol, 99:1160-74
Amirudin R (2007). Fibrosis Hati. Dalam : Sulaiman A. Akbar HN. Lesmana LA.
Noer MS. Buku Ajar Ilmu Penyakit Hati 1. Jakarta: Penerbit Jayabadi :
329-33
Al-Ghamdi AS (2010). FibroScan: A Noninvasive Test of Liver Fibrosis
Assessment.
[online]
Available
at:
http://www.ncbi.nlm.nih.gov/pubmed/19858635
Albert EG, Porcelijn L, Folman C, et al (1998). Thrombopoietin : Modes of
Action Role in Platelet Disorders and New Drugs. Available from :
http://www.slz.nl/hora/literatu/pages/1998/tpo.htm
Amellal N, Raissouni F, Achour J, et al (2009). Correlation study between liver
biopsy and transient elastometry (FIBROSCAN) for the assessment of
fibrosis during viral hepatitis C. Arab journal of Gastroenterology.
10: AB10-AB17.
Bataller R. Brenner DA. 2005. Liver Fibrosis Dalam The Journal of Clinical
Investigation. 115 : 209-16
Brunt EM (2000). Grading and Staging the Histopatological Lesions of Chronic
Hepatitis : The Knodell Histology Activity Index and Beyond. Hepatology
: 241-6
Carstensen EL, Parker KJ, Lerner RM (2008). Elastrography in the management
of liver disease. Ultrasound in Med. & Biol., Vol 34, No. 10,pp. 15351546, 2008.
Collier J, Bassendine M (2002). How to respond to abnormal liver function tests.
Clin Med JRCPL;2:406–9
Friedman SL (2003). Liver Fibrosis-From Bench to Bedside. J. Hepatol. 38: S38S53
Fujiwara S, Hongou Y, Miyaji K, et al (2007). Relationship Between Liver
Fibrosis Noninvasively Measured by FibroScan and Blood Test. Bulletin
of the Osaka Medical College; 53: 93-105
Forns X, Ampurdan’es S, Llovet JM, et al (2002). Identification of chronic
hepatic fibrosis by a simple predictive model. Hepatology; 36: 968-92
Grigorescu M (2010). Noninvasive Biochemical Markers of Liver Fibrosis.
University of Medicine and Pharmacy. [online] Available at:
http://168.105.175.200/Csiszar/644_07/09_20_07/Grigorescu%2006%2re
v.pdf.
Gressner AM. Weiskirchen R (2006). Modern Pathogenic Concepts of Liver
Fibrosis Suggest Stellate Cells and TGF - α as Major Players and
Therapeutic Targets. Journal of Cellular and Molecular Medicine.10: 7699
46
Ghadir MR, Riahin AA, Havaspour A, et al (2010). The Relationship between
Lipid Profile and Severity of Liver Damage in Cirrhotic Patients. Hepatitis
Monthly; 10(4): 285-288
Guzelbulut F, Akkan CZ, Sezikli M, et al (2011). AST-platelet ratio index, Forns
index and FIB-4 in the prediction of significant fibrosis and cirrhosis in
patients with chronic hepatitis C. Turk J Gastroenterol; 22(3): 279-285
Hung CH, Lu SN, Wang JH, et al (2003). Correlation between ultrasonographic
and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J
gastroenterol; 38: 153-157
Hui AY, Chan HLY, Wong VWS, et al (2005). Identification of chronic hepatitis
B patients without significant liver fibrosis by a simple noninvasive
predictive models. Am J Gastroenterol; 616-23
Kwang GL, Yeon SS, Hyonggin A, Soon HU, Eun SJ, Bora K, et al (2010).
Usefullness of Non-invasive Markers for Predicting Liver Cirrhosis in
Patients with Chronic Hepatitis B. Journal of Gastroenterology and
Hepatology, 25(1): 94-100
Kajihara M, Kato S, Okazak Y, et al (2003). A role of Autoantibody-Mediated
Platelet Destruction in Thrombocytopenia in Patients with cirrhosis.
Hepatology. 37: 1267-76
Kun Z, Chun FG, Yun PZ, et al (2010). Simpler Score of Routine Laboratory
Tests Predicts Liver Fibrosis in Patients with Chronic Hepatitis B. Journal
of Gastroenterology and Hepatology. 96(4): 1569-77
Kim SU, Han KH, Ahn SA (2010). Transient elastography in chronic hepatitis B:
An asian perspective. World J Gastroenterol; 16(41): 5173-5180
Ledinghen VD, Vergniol J (2008). Transient elastography (FibroScan).
Gastroenterol Clin Bio. 32: 58-67
Marcellin (2009). Non-invasive assessment of liver fibrosis by measurement of
stiffness in patient with chronic hepatitis B. Liver Internationale, 29(2):
242-247
Malekzadeh R, Poustchi H (2011). Fibroscan for assessing liver fibrosis: An
acceptable alternative for liver biopsy. Hepat Mon ;11(3):157-158
Nagamine T, Ohtuka T, Takehara K, et al (1996). Thrombocytopenia associated
with Hepatitis C viral infection. Journal of Hepatology. 24: 135-140
Olariu M, Olariu C, Olteanu D (2010). Thrombocytopenia in Chronic Hepatitis C.
J Gastrointestin Liver Dis, 19(4):381-385
Pinzani M, Rombouts K, Colagrande S (2005). Fibrosis in Chronic Liver Disease:
Diagnosis and Management. Journal of Hepatology. 42: 22-36
Poynard T, Morra R, Ingiliz P, et al (2008). Assesment of Liver Fibrosis :
Noninvasive Means : 14:163-173
Sembiring J (2009). “Korelasi kadar thrombopoietin serum dengan fibrosis hati
pada penderita hepatitis kronik.” Diss; 1-16
Soemohardjo S, Gunawan S (2009). Hepatitis B Kronik. Dalam: A.W. Sudoyo,
B. Setiyohadi, I. Alwi, M. Simadibrata, S. Setiati, eds., 2009. Buku Ajar
Ilmu Penyakit Dalam. Jakarta: Penerbit InternaPublishing: 653-57.
Sebastiani G, Alberti A (2006). Non invasive fibrosis biomarkers reduce but not
substitute the need for liver biopsy. Gastroenterol; 12 : 3682-94
47
Sirli R, Sporea I, et al (2010). A Comparative Study of Non-Invasive Methods for
Fibrosis Assessment in Chronic HCV Infection. Hepatitis Monthly; 10(2):
88-94
Sherlock S. Dooley J (1997). The Hematology of Liver Disease. Dalam Disease of
The Liver and Billiary System. USA 10th Blackwell Scientific Publication.
USA : 43-62
Takemoto R (2009). Validity of FibroScan values for predicting hepatic fibrosis
stage in patients with chronic HCV infection. Journal of Digestive
Diseases. 10 : 145-48
Tsukada S, Parsons CJ, Rippe RA (2006). Mechanism of Liver fibrosis. Clinica
Chimica Acta; 364: 33-60
Wai CT, Cheng CL, Wee A, et al (2006). Non-invasive models for predicting
histology in patients with chronic hepatitis B. Liver International: 26: 66672
Wang JH, Changchien CH ( 2009 ). Fibroscan and ultrasonography in the
prediction of hepatic fibrosis in patients with chronic viral hepatitis. J
Gastroenterol 44: 439-446.
Wolber EM, Jelkmann W (2002). Thrombopoietin : The Novel Hepatic Hormone.
News Physiol Sci. 17: 6-10
Wu SD, Wang JY, Li L ( 2010 ). Staging of liver fibrosis in chronic hepatitis B
patients with a composite predictive model :A comparative study.
Ziol M, Handra-Luca A, Kettaneh A, et al (2005). Noninvasive assessment of
liver fibrosis by measurement of stiffness in patient with chronic hepatitis
C. Hepatology, 41(1); 48-54.
Zain LH (2006). Hepatitis B dan Permasalahannya. Orasi Ilmiah pada upacara
peringatan Dies Natalis ke-54 UNIVERSITAS SUMATERA UTARA
(USU)
48
DAFTAR PUSTAKA
Akbar HN (2007). Hepatitis B dan Hepatitis C. Dalam : Sulaiman A. Akbar HN.
Lesmana LA. Noer MS. Ed: Buku Ajar Penyakit Hati. Edisi 1. Jakarta:
FK.UI; 201-8
Afdhal NH, Nunes D (2004). Evaluation of liver fibrosis: a concise review. Am J
Gastroenterol, 99:1160-74
Amirudin R (2007). Fibrosis Hati. Dalam : Sulaiman A. Akbar HN. Lesmana LA.
Noer MS. Buku Ajar Ilmu Penyakit Hati 1. Jakarta: Penerbit Jayabadi :
329-33
Al-Ghamdi AS (2010). FibroScan: A Noninvasive Test of Liver Fibrosis
Assessment.
[online]
Available
at:
http://www.ncbi.nlm.nih.gov/pubmed/19858635
Albert EG, Porcelijn L, Folman C, et al (1998). Thrombopoietin : Modes of
Action Role in Platelet Disorders and New Drugs. Available from :
http://www.slz.nl/hora/literatu/pages/1998/tpo.htm
Amellal N, Raissouni F, Achour J, et al (2009). Correlation study between liver
biopsy and transient elastometry (FIBROSCAN) for the assessment of
fibrosis during viral hepatitis C. Arab journal of Gastroenterology.
10: AB10-AB17.
Bataller R. Brenner DA. 2005. Liver Fibrosis Dalam The Journal of Clinical
Investigation. 115 : 209-16
Brunt EM (2000). Grading and Staging the Histopatological Lesions of Chronic
Hepatitis : The Knodell Histology Activity Index and Beyond. Hepatology
: 241-6
Carstensen EL, Parker KJ, Lerner RM (2008). Elastrography in the management
of liver disease. Ultrasound in Med. & Biol., Vol 34, No. 10,pp. 15351546, 2008.
Collier J, Bassendine M (2002). How to respond to abnormal liver function tests.
Clin Med JRCPL;2:406–9
Friedman SL (2003). Liver Fibrosis-From Bench to Bedside. J. Hepatol. 38: S38S53
Fujiwara S, Hongou Y, Miyaji K, et al (2007). Relationship Between Liver
Fibrosis Noninvasively Measured by FibroScan and Blood Test. Bulletin
of the Osaka Medical College; 53: 93-105
Forns X, Ampurdan’es S, Llovet JM, et al (2002). Identification of chronic
hepatic fibrosis by a simple predictive model. Hepatology; 36: 968-92
Grigorescu M (2010). Noninvasive Biochemical Markers of Liver Fibrosis.
University of Medicine and Pharmacy. [online] Available at:
http://168.105.175.200/Csiszar/644_07/09_20_07/Grigorescu%2006%2re
v.pdf.
Gressner AM. Weiskirchen R (2006). Modern Pathogenic Concepts of Liver
Fibrosis Suggest Stellate Cells and TGF - α as Major Players and
Therapeutic Targets. Journal of Cellular and Molecular Medicine.10: 7699
46
Ghadir MR, Riahin AA, Havaspour A, et al (2010). The Relationship between
Lipid Profile and Severity of Liver Damage in Cirrhotic Patients. Hepatitis
Monthly; 10(4): 285-288
Guzelbulut F, Akkan CZ, Sezikli M, et al (2011). AST-platelet ratio index, Forns
index and FIB-4 in the prediction of significant fibrosis and cirrhosis in
patients with chronic hepatitis C. Turk J Gastroenterol; 22(3): 279-285
Hung CH, Lu SN, Wang JH, et al (2003). Correlation between ultrasonographic
and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J
gastroenterol; 38: 153-157
Hui AY, Chan HLY, Wong VWS, et al (2005). Identification of chronic hepatitis
B patients without significant liver fibrosis by a simple noninvasive
predictive models. Am J Gastroenterol; 616-23
Kwang GL, Yeon SS, Hyonggin A, Soon HU, Eun SJ, Bora K, et al (2010).
Usefullness of Non-invasive Markers for Predicting Liver Cirrhosis in
Patients with Chronic Hepatitis B. Journal of Gastroenterology and
Hepatology, 25(1): 94-100
Kajihara M, Kato S, Okazak Y, et al (2003). A role of Autoantibody-Mediated
Platelet Destruction in Thrombocytopenia in Patients with cirrhosis.
Hepatology. 37: 1267-76
Kun Z, Chun FG, Yun PZ, et al (2010). Simpler Score of Routine Laboratory
Tests Predicts Liver Fibrosis in Patients with Chronic Hepatitis B. Journal
of Gastroenterology and Hepatology. 96(4): 1569-77
Kim SU, Han KH, Ahn SA (2010). Transient elastography in chronic hepatitis B:
An asian perspective. World J Gastroenterol; 16(41): 5173-5180
Ledinghen VD, Vergniol J (2008). Transient elastography (FibroScan).
Gastroenterol Clin Bio. 32: 58-67
Marcellin (2009). Non-invasive assessment of liver fibrosis by measurement of
stiffness in patient with chronic hepatitis B. Liver Internationale, 29(2):
242-247
Malekzadeh R, Poustchi H (2011). Fibroscan for assessing liver fibrosis: An
acceptable alternative for liver biopsy. Hepat Mon ;11(3):157-158
Nagamine T, Ohtuka T, Takehara K, et al (1996). Thrombocytopenia associated
with Hepatitis C viral infection. Journal of Hepatology. 24: 135-140
Olariu M, Olariu C, Olteanu D (2010). Thrombocytopenia in Chronic Hepatitis C.
J Gastrointestin Liver Dis, 19(4):381-385
Pinzani M, Rombouts K, Colagrande S (2005). Fibrosis in Chronic Liver Disease:
Diagnosis and Management. Journal of Hepatology. 42: 22-36
Poynard T, Morra R, Ingiliz P, et al (2008). Assesment of Liver Fibrosis :
Noninvasive Means : 14:163-173
Sembiring J (2009). “Korelasi kadar thrombopoietin serum dengan fibrosis hati
pada penderita hepatitis kronik.” Diss; 1-16
Soemohardjo S, Gunawan S (2009). Hepatitis B Kronik. Dalam: A.W. Sudoyo,
B. Setiyohadi, I. Alwi, M. Simadibrata, S. Setiati, eds., 2009. Buku Ajar
Ilmu Penyakit Dalam. Jakarta: Penerbit InternaPublishing: 653-57.
Sebastiani G, Alberti A (2006). Non invasive fibrosis biomarkers reduce but not
substitute the need for liver biopsy. Gastroenterol; 12 : 3682-94
47
Sirli R, Sporea I, et al (2010). A Comparative Study of Non-Invasive Methods for
Fibrosis Assessment in Chronic HCV Infection. Hepatitis Monthly; 10(2):
88-94
Sherlock S. Dooley J (1997). The Hematology of Liver Disease. Dalam Disease of
The Liver and Billiary System. USA 10th Blackwell Scientific Publication.
USA : 43-62
Takemoto R (2009). Validity of FibroScan values for predicting hepatic fibrosis
stage in patients with chronic HCV infection. Journal of Digestive
Diseases. 10 : 145-48
Tsukada S, Parsons CJ, Rippe RA (2006). Mechanism of Liver fibrosis. Clinica
Chimica Acta; 364: 33-60
Wai CT, Cheng CL, Wee A, et al (2006). Non-invasive models for predicting
histology in patients with chronic hepatitis B. Liver International: 26: 66672
Wang JH, Changchien CH ( 2009 ). Fibroscan and ultrasonography in the
prediction of hepatic fibrosis in patients with chronic viral hepatitis. J
Gastroenterol 44: 439-446.
Wolber EM, Jelkmann W (2002). Thrombopoietin : The Novel Hepatic Hormone.
News Physiol Sci. 17: 6-10
Wu SD, Wang JY, Li L ( 2010 ). Staging of liver fibrosis in chronic hepatitis B
patients with a composite predictive model :A comparative study.
Ziol M, Handra-Luca A, Kettaneh A, et al (2005). Noninvasive assessment of
liver fibrosis by measurement of stiffness in patient with chronic hepatitis
C. Hepatology, 41(1); 48-54.
Zain LH (2006). Hepatitis B dan Permasalahannya. Orasi Ilmiah pada upacara
peringatan Dies Natalis ke-54 UNIVERSITAS SUMATERA UTARA
(USU)
48